Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹10,233 Cr₹5.27 Cr₹-740 Cr₹605 Cr₹-7.81 Cr

What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Financing Activities ratio of MANKIND PHARMA is ₹10,233 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹10,233 Cr
Mar2024₹5.27 Cr
Mar2023₹-740 Cr
Mar2022₹605 Cr
Mar2021₹-7.81 Cr

How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹10,233 Cr
194,066.22
Mar2024 ₹5.27 Cr
Positive
Mar2023 ₹-740 Cr
Negative
Mar2022 ₹605 Cr
Positive
Mar2021 ₹-7.81 Cr -

Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹83,395.9 Cr 1% -1.3% -11.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1%

-1.3%

-11.5%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses